Brain Activation in Response to Low-Calorie Food Pictures: An Explorative Analysis of a Randomized Trial With Dapagliflozin and Exenatide

BACKGROUND AND AIM: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) induce less weight loss than expected. This may be explained by SGLT2i-induced alterations in central reward and satiety circuits, contributing to increased appetite and food intake. This hyperphagia may be specific to high-calor...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ruiten, Charlotte C., Veltman, Dick J., Nieuwdorp, Max, IJzerman, Richard G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114766/
https://www.ncbi.nlm.nih.gov/pubmed/35600575
http://dx.doi.org/10.3389/fendo.2022.863592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114766/
https://www.ncbi.nlm.nih.gov/pubmed/35600575
http://dx.doi.org/10.3389/fendo.2022.863592

Ejemplares similares